R5R-33488-49077
3 vaccinations
1 coded response
7 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 112 / NY
- Registered
- 2022-08-13
- Relationship
- Child or adolescent in my care
- Guardian
- 5WH-14668-34146
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-07-14
Dose 1 — Pfizer-BioNTechCo-administered: Polio:Tetanus
-
2022-08-12
Dose 2 — Pfizer-BioNTech
-
2022-08-13
Registered in v-safe
-
2022-08-13
Survey response — days 1–6 daily, dose 2, dependentMedDRA: Cough — Feeling: Fair · Fever · Fatigue or tirednessFree text: CoughMedDRA releases: 2024-11 · check-in free text available
- 2022-08-15
- 2022-08-26
- 2022-09-18
- 2022-09-25
-
2022-10-07
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2022-11-07
- 2023-01-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-14 | Pfizer-BioNTech | Polio:Tetanus |
| 2 | 2022-08-12 | Pfizer-BioNTech | No |
| 3 | 2022-10-07 | Pfizer-BioNTech | Flu |
Free text
Release 12 — days 1–6 daily, dose 2, dependent
Systemic reaction (other): Cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Cough | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release